Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
FRA:YMP3
Delisted

Symphony Holdings Limited Stock Price (Quote)

Frankfurt Stock Exchange
Open Broker Account
0.0890€
+0 (+0%)
At Close: Aug 17, 2022
Forecast Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days 0.0890€ 0.0890€ Wednesday, 17th Aug 2022 YMP3.F stock ended at 0.0890€. During the day the stock fluctuated 0% from a day low at 0.0890€ to a day high of 0.0890€.
90 days 0.0890€ 0.0890€
52 weeks 0.0890€ 0.0905€

Historical Symphony Holdings Limited prices

Date Open High Low Close Volume
Mar 26, 2020 0.0920€ 0.0920€ 0.0920€ 0.0920€ 40 000
Mar 25, 2020 0.0930€ 0.0930€ 0.0930€ 0.0930€ 40 000
Mar 24, 2020 0.0915€ 0.0915€ 0.0915€ 0.0925€ 40 000
Mar 23, 2020 0.0910€ 0.0910€ 0.0910€ 0.0910€ 40 000
Mar 20, 2020 0.0910€ 0.0910€ 0.0910€ 0.0910€ 40 000
Mar 19, 2020 0.0905€ 0.109€ 0.0905€ 0.109€ 40 000
Mar 18, 2020 0.0885€ 0.0885€ 0.0885€ 0.0885€ 10 000
Mar 17, 2020 0.0885€ 0.0885€ 0.0885€ 0.0885€ 10 000
Mar 16, 2020 0.0865€ 0.0885€ 0.0865€ 0.0885€ 10 000
Mar 13, 2020 0.0895€ 0.0895€ 0.0895€ 0.0895€ 10 000
Mar 12, 2020 0.0905€ 0.0905€ 0.0905€ 0.0905€ 10 000
Mar 11, 2020 0.0935€ 0.0935€ 0.0935€ 0.0935€ 10 000
Mar 10, 2020 0.0935€ 0.0935€ 0.0935€ 0.0935€ 10 000
Mar 09, 2020 0.0935€ 0.0935€ 0.0935€ 0.0935€ 10 000
Mar 06, 2020 0.0970€ 0.0970€ 0.0970€ 0.0970€ 10 000
Mar 05, 2020 0.0990€ 0.0990€ 0.0990€ 0.0990€ 10 000
Mar 04, 2020 0.0965€ 0.0965€ 0.0965€ 0.0965€ 10 000
Mar 03, 2020 0.0965€ 0.0965€ 0.0965€ 0.0965€ 10 000
Mar 02, 2020 0.0975€ 0.0975€ 0.0975€ 0.0975€ 10 000
Feb 28, 2020 0.0975€ 0.0975€ 0.0975€ 0.0975€ 10 000
Feb 27, 2020 0.0975€ 0.0975€ 0.0975€ 0.0975€ 10 000
Feb 26, 2020 0.0965€ 0.0965€ 0.0965€ 0.0965€ 10 000
Feb 25, 2020 0.0980€ 0.0980€ 0.0980€ 0.0980€ 10 000
Feb 24, 2020 0.101€ 0.101€ 0.101€ 0.101€ 10 000
Feb 21, 2020 0.102€ 0.102€ 0.102€ 0.102€ 10 000
Click to get the best stock tips daily for free!

About Symphony Holdings Limited

Symphony Holdings Limited Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,... YMP3.F Profile

Golden Star

Ticker Date Change Price
WMT May 06 0.718% $59.87
UNP May 06 2.80% $239.21
JPM May 06 1.90% $192.00
INGR May 03 3.40% $114.56
BNDX May 03 0.247% $48.68
BBCA May 03 0.99% $65.44
ADTH May 03 5.86% $3.24
ASH May 03 1.78% $95.85
INVH May 03 0.90% $34.39
INTU May 03 0.502% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT